Capecitabine: Medgend

Capecitabine FDA Approved Drugs

CAPECITABINE [Capecitabine^{C₁₅H₂₂FN₃O₆}]

150mg (oral tablet)

500mg (oral tablet)

Accord Hlthcare^{Apr 23, 2015}
Amneal Pharms^{Feb 28, 2017}
Mylan Pharms Inc^{Aug 8, 2014}
Shilpa Medicare Ltd^{Dec 12, 2016}
Teva Pharms Usa^{Sep 16, 2013}
West-ward Pharms Int^{Jul 14, 2016}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

IXEMPRA KIT [Ixabepilone^{C₂₇H₄₂N₂O₅S}]

15mg/vial (iv (infusion) injectable)

45mg/vial (iv (infusion) injectable)

R-pharm Us Llc^{Oct 16, 2007}

A method of treating cancer in a patient comprising administering ixabepilone or pharmaceutical compositions comprising ixabepilone.
Method of treating breast cancer by administering ixabepilone; a method of treating a cancer responsible to microtubule stabilization by administering ixabepilone.
Method of treating cancer in a patient comprising intravenously administering to the patient ixabepilone diluted in a parenteral diluent.
Method of treating cancer, iv admin, lyophylized ixabepilone diluted, every week or 3 weeks; lyophilized ixabepilone with solvent(dehydrated ethanol) diluted to concentration of 0.1mg/ml to 0.9mg/ml.
Method of treating patient comprising mixing first and second vials of product comprising lyophilized ixabepilone to provide an epothilone analog solution, diluting solution with a suitable diluent to prepare intravenous formulation for pt.
Use of ixabepilone in combination with capecitabine in treatment of metastasis breast cancer.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

VISTOGARD [Uridine Triacetate^{C₁₅H₁₈N₂O₉}]

10gm/packet (oral granule)

Wellstat Therap^{Dec 11, 2015}

Emergency treatment of adult & pediatric patients following fluorouracil or capecitabine overdose,or who exhibit early-onset,severe or life-threatening cardiac or cns toxicity or unusually severe adverse reactions within 96 hours.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

XELODA [Capecitabine^{C₁₅H₂₂FN₃O₆}]

150mg (oral tablet)

500mg (oral tablet)

Hoffmann La Roche^{Apr 30, 1998}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.